Dr. Alan Xiaodong Zhuang is a group leader and MRC-CDA Fellow in the Infection and Immunity division at UCL. His background includes a PhD from the University of Birmingham, where he identified cancer targets and developed immunotherapy (CAR-T and vaccine) for targeting tumor vasculature. During his postdoctoral period at the University of Oxford, his focus shifted to understanding the interplay between the host circadian clock and viral infections.